1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Teriete, P. Banerji, S. Blundell, C.D. Kahmann, J.D. Pickford, A.R. Wright, A.J. Campbell, I.D. Jackson, D.G. Day, A.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Mol.Cell MOCEFL 2168 1097-2765 13 483 496 10.1016/S1097-2765(04)00080-2 14992719 Structure of the Regulatory Hyaluronan Binding Domain in the Inflammatory Leukocyte Homing Receptor CD44. 2004 US Cell(Cambridge,Mass.) CELLB5 0998 0092-8674 56 1057 1062 10.1016/0092-8674(89)90638-7 A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. 1989 US Cell(Cambridge,Mass.) CELLB5 0998 0092-8674 56 1063 1072 10.1016/0092-8674(89)90639-9 A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. 1989 US Cell(Cambridge,Mass.) CELLB5 0998 0092-8674 61 1303 1313 10.1016/0092-8674(90)90694-A CD44 is the principal cell surface receptor for hyaluronate. 1990 US J.Cell Biol. JCLBA3 2019 0021-9525 122 257 264 10.1083/jcb.122.1.257 Identification of hyaluronic acid binding sites in the extracellular domain of CD44. 1993 US Cell(Cambridge,Mass.) CELLB5 0998 0092-8674 86 767 775 10.1016/S0092-8674(00)80151-8 Solution Structure of the Link Module: A Hyaluronan-Binding Domain Involved in Extracellular Matrix Stability and Cell Migration 1996 US J.Biol.Chem. JBCHA3 0071 0021-9258 273 338 343 10.1074/jbc.273.1.338 Identification of CD44 residues important for hyaluronan binding and delineation of the binding site 1998 US Cancer Res. CNREA8 0400 0008-5472 58 3736 3742 Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding 1998 US Protein Expr.Purif. PEXPEJ 0757 1046-5928 14 371 381 10.1006/prep.1998.0971 Characterization of a functional hyaluronan-binding domain from the human CD44 molecule expressed in Escherichia coli 1998 10.2210/pdb1poz/pdb pdb_00001poz 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 17601.486 CD44 antigen HYALURONAN BINDING DOMAIN 1 man polymer Phagocytic glycoprotein I, PGP-1, HUTCH-I, Extracellular matrix receptor-III, ECMR-III, GP90 lymphocyte homing/adhesion receptor, Hermes antigen, Hyaluronate receptor, Heparan sulfate proteoglycan, Epican, CDw44 no no AQIDLNITCRFAGVFHVEKNGRYSISRTEAADLCKAFNSTLPTMAQMEKALSIGFETCRYGFIEGHVVIPRIHPNSICAA NNTGVYILTSNTSQYDTYCFNASAPPEEDCTSVTDLPNAFDGPITITIVNRDGTRYVQKGEYRTNPEDIYPSNPTDDDV AQIDLNITCRFAGVFHVEKNGRYSISRTEAADLCKAFNSTLPTMAQMEKALSIGFETCRYGFIEGHVVIPRIHPNSICAA NNTGVYILTSNTSQYDTYCFNASAPPEEDCTSVTDLPNAFDGPITITIVNRDGTRYVQKGEYRTNPEDIYPSNPTDDDV A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample CD44 9606 Homo sapiens 562 Escherichia coli BL21(DE3)pLysS pET Vector pET19b atom_site database_2 diffrn diffrn_radiation diffrn_radiation_wavelength pdbx_nmr_exptl_sample pdbx_nmr_sample_details pdbx_nmr_software pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Atomic model Data collection Database references Derived calculations Experimental preparation 1 0 2004-03-16 1 1 2008-04-29 1 2 2011-07-13 2 0 2021-10-27 _atom_site.occupancy _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_sample_details.contents _pdbx_nmr_sample_details.label _pdbx_nmr_sample_details.solvent_system _pdbx_nmr_sample_details.type _pdbx_nmr_software.name _pdbx_nmr_spectrometer.manufacturer _pdbx_nmr_spectrometer.model Link module of the human TSG-6 Conformation of the bound Link module of the human TSG-6 to a hyaluronic acid octamer. RCSB Y RCSB 2003-06-16 REL REL structures with the least restraint violations,structures with the lowest energy,target function 500 20 3D_15N-separated_NOESY 2D NOESY 2D NOESY 2D TOCSY HMQC-J CBCA(CO)NH NH-Exchange HSQC 1 mM [U-13C; U-15N] 1 mM [U-15N] 1 mM [U-15N] 1 mM natural abundance 1 mM natural abundance <5mM 6.5 ambient 298 K The structures are calculated from 2271 restraints, 2168 are NOE based, 47 dihedral constraints and 56 distance restraints from hydrogen bonds torsion angle dynamics simulated annealing refinement by molecular dynamics 1 lowest energy 1 mM [U-13C; U-15N] protein, 95% H2O/5% D2O sample_1 95% H2O/5% D2O solution 1 mM [U-15N] protein, 95% H2O/5% D2O sample_2 95% H2O/5% D2O solution 1 mM [U-15N] protein, 100% D2O sample_3 100% D2O solution 1 mM protein, 95% H2O/5% D2O sample_4 95% H2O/5% D2O solution 1 mM protein, 100% D2O sample_5 100% D2O solution Brunger, A.T. structure solution CNS 1.1 MSI, San Diego processing Felix 2.3 Pickford, A.R. structure solution SOPHIE 1.0 Goddard, T.D. data analysis Sparky 2.0 Xia, T data analysis XEASY 3.13 Pickford, A.R. refinement SOPHIE 1.0 750 GE OMEGA 600 GE OMEGA 500 GE OMEGA ALA 20 n 1 ALA 20 A GLN 21 n 2 GLN 21 A ILE 22 n 3 ILE 22 A ASP 23 n 4 ASP 23 A LEU 24 n 5 LEU 24 A ASN 25 n 6 ASN 25 A ILE 26 n 7 ILE 26 A THR 27 n 8 THR 27 A CYS 28 n 9 CYS 28 A ARG 29 n 10 ARG 29 A PHE 30 n 11 PHE 30 A ALA 31 n 12 ALA 31 A GLY 32 n 13 GLY 32 A VAL 33 n 14 VAL 33 A PHE 34 n 15 PHE 34 A HIS 35 n 16 HIS 35 A VAL 36 n 17 VAL 36 A GLU 37 n 18 GLU 37 A LYS 38 n 19 LYS 38 A ASN 39 n 20 ASN 39 A GLY 40 n 21 GLY 40 A ARG 41 n 22 ARG 41 A TYR 42 n 23 TYR 42 A SER 43 n 24 SER 43 A ILE 44 n 25 ILE 44 A SER 45 n 26 SER 45 A ARG 46 n 27 ARG 46 A THR 47 n 28 THR 47 A GLU 48 n 29 GLU 48 A ALA 49 n 30 ALA 49 A ALA 50 n 31 ALA 50 A ASP 51 n 32 ASP 51 A LEU 52 n 33 LEU 52 A CYS 53 n 34 CYS 53 A LYS 54 n 35 LYS 54 A ALA 55 n 36 ALA 55 A PHE 56 n 37 PHE 56 A ASN 57 n 38 ASN 57 A SER 58 n 39 SER 58 A THR 59 n 40 THR 59 A LEU 60 n 41 LEU 60 A PRO 61 n 42 PRO 61 A THR 62 n 43 THR 62 A MET 63 n 44 MET 63 A ALA 64 n 45 ALA 64 A GLN 65 n 46 GLN 65 A MET 66 n 47 MET 66 A GLU 67 n 48 GLU 67 A LYS 68 n 49 LYS 68 A ALA 69 n 50 ALA 69 A LEU 70 n 51 LEU 70 A SER 71 n 52 SER 71 A ILE 72 n 53 ILE 72 A GLY 73 n 54 GLY 73 A PHE 74 n 55 PHE 74 A GLU 75 n 56 GLU 75 A THR 76 n 57 THR 76 A CYS 77 n 58 CYS 77 A ARG 78 n 59 ARG 78 A TYR 79 n 60 TYR 79 A GLY 80 n 61 GLY 80 A PHE 81 n 62 PHE 81 A ILE 82 n 63 ILE 82 A GLU 83 n 64 GLU 83 A GLY 84 n 65 GLY 84 A HIS 85 n 66 HIS 85 A VAL 86 n 67 VAL 86 A VAL 87 n 68 VAL 87 A ILE 88 n 69 ILE 88 A PRO 89 n 70 PRO 89 A ARG 90 n 71 ARG 90 A ILE 91 n 72 ILE 91 A HIS 92 n 73 HIS 92 A PRO 93 n 74 PRO 93 A ASN 94 n 75 ASN 94 A SER 95 n 76 SER 95 A ILE 96 n 77 ILE 96 A CYS 97 n 78 CYS 97 A ALA 98 n 79 ALA 98 A ALA 99 n 80 ALA 99 A ASN 100 n 81 ASN 100 A ASN 101 n 82 ASN 101 A THR 102 n 83 THR 102 A GLY 103 n 84 GLY 103 A VAL 104 n 85 VAL 104 A TYR 105 n 86 TYR 105 A ILE 106 n 87 ILE 106 A LEU 107 n 88 LEU 107 A THR 108 n 89 THR 108 A SER 109 n 90 SER 109 A ASN 110 n 91 ASN 110 A THR 111 n 92 THR 111 A SER 112 n 93 SER 112 A GLN 113 n 94 GLN 113 A TYR 114 n 95 TYR 114 A ASP 115 n 96 ASP 115 A THR 116 n 97 THR 116 A TYR 117 n 98 TYR 117 A CYS 118 n 99 CYS 118 A PHE 119 n 100 PHE 119 A ASN 120 n 101 ASN 120 A ALA 121 n 102 ALA 121 A SER 122 n 103 SER 122 A ALA 123 n 104 ALA 123 A PRO 124 n 105 PRO 124 A PRO 125 n 106 PRO 125 A GLU 126 n 107 GLU 126 A GLU 127 n 108 GLU 127 A ASP 128 n 109 ASP 128 A CYS 129 n 110 CYS 129 A THR 130 n 111 THR 130 A SER 131 n 112 SER 131 A VAL 132 n 113 VAL 132 A THR 133 n 114 THR 133 A ASP 134 n 115 ASP 134 A LEU 135 n 116 LEU 135 A PRO 136 n 117 PRO 136 A ASN 137 n 118 ASN 137 A ALA 138 n 119 ALA 138 A PHE 139 n 120 PHE 139 A ASP 140 n 121 ASP 140 A GLY 141 n 122 GLY 141 A PRO 142 n 123 PRO 142 A ILE 143 n 124 ILE 143 A THR 144 n 125 THR 144 A ILE 145 n 126 ILE 145 A THR 146 n 127 THR 146 A ILE 147 n 128 ILE 147 A VAL 148 n 129 VAL 148 A ASN 149 n 130 ASN 149 A ARG 150 n 131 ARG 150 A ASP 151 n 132 ASP 151 A GLY 152 n 133 GLY 152 A THR 153 n 134 THR 153 A ARG 154 n 135 ARG 154 A TYR 155 n 136 TYR 155 A VAL 156 n 137 VAL 156 A GLN 157 n 138 GLN 157 A LYS 158 n 139 LYS 158 A GLY 159 n 140 GLY 159 A GLU 160 n 141 GLU 160 A TYR 161 n 142 TYR 161 A ARG 162 n 143 ARG 162 A THR 163 n 144 THR 163 A ASN 164 n 145 ASN 164 A PRO 165 n 146 PRO 165 A GLU 166 n 147 GLU 166 A ASP 167 n 148 ASP 167 A ILE 168 n 149 ILE 168 A TYR 169 n 150 TYR 169 A PRO 170 n 151 PRO 170 A SER 171 n 152 SER 171 A ASN 172 n 153 ASN 172 A PRO 173 n 154 PRO 173 A THR 174 n 155 THR 174 A ASP 175 n 156 ASP 175 A ASP 176 n 157 ASP 176 A ASP 177 n 158 ASP 177 A VAL 178 n 159 VAL 178 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N ILE 22 A N ILE 3 A O THR 144 A O THR 125 A N ILE 147 A N ILE 128 A O TYR 155 A O TYR 136 A N ILE 22 A N ILE 3 A O THR 144 A O THR 125 A N ILE 143 A N ILE 124 A O GLY 159 A O GLY 140 A N PHE 30 A N PHE 11 A O VAL 33 A O VAL 14 A N THR 59 A N THR 40 A O PHE 119 A O PHE 100 A O VAL 87 A O VAL 68 A N GLY 80 A N GLY 61 A N PHE 81 A N PHE 62 A O ASP 115 A O ASP 96 1 A A HE2 HB3 HIS ASP 35 115 1.28 1 A A HA3 HE1 GLY TYR 80 117 1.33 1 A A HD1 HG23 HIS THR 35 76 1.34 2 A A HG3 HB2 ARG PHE 29 34 1.25 2 A A HA H PHE ASP 30 128 1.29 2 A A HD1 HG22 HIS THR 35 76 1.30 2 A A O HA CYS PHE 28 34 1.57 3 A A HD1 HG21 HIS THR 35 76 1.27 3 A A HG2 H ARG ALA 78 98 1.29 3 A A HG12 HE2 VAL TYR 132 155 1.30 3 A A HB2 HE1 CYS PHE 28 30 1.33 3 A A HB HB3 THR HIS 27 35 1.34 4 A A HG3 HB2 ARG PHE 29 34 1.30 4 A A H HG13 THR ILE 133 147 1.31 4 A A HB2 HG3 SER GLN 45 113 1.34 4 A A HD11 HD12 LEU ILE 24 147 1.35 5 A A HA HB2 THR GLN 62 65 1.17 5 A A HG3 HB2 ARG PHE 29 34 1.22 5 A A HG13 H ILE GLU 82 83 1.25 5 A A HD1 HG21 HIS THR 35 76 1.29 5 A A O HA CYS PHE 28 34 1.58 6 A A HG3 HB2 ARG PHE 29 34 1.24 6 A A HB2 HE1 CYS PHE 28 30 1.32 6 A A HG13 H ILE GLU 82 83 1.35 7 A A HG3 HB2 ARG PHE 29 34 1.29 7 A A HD12 H LEU ASN 107 110 1.30 7 A A HG13 H ILE GLU 82 83 1.34 7 A A HG H LEU SER 107 109 1.34 7 A A H HE2 VAL TYR 132 155 1.34 8 A A HG3 HB2 ARG PHE 29 34 1.29 8 A A HE2 HB3 HIS ASP 35 115 1.30 8 A A HD12 HA LEU LYS 24 38 1.33 9 A A HB3 HE1 CYS PHE 28 30 1.18 9 A A HD1 HG21 HIS THR 35 76 1.25 9 A A HB HB3 THR HIS 27 35 1.33 9 A A HB1 HB3 ALA LEU 55 135 1.34 10 A A HB2 HE1 CYS PHE 28 30 1.19 10 A A HG3 HB2 ARG PHE 29 34 1.31 10 A A HD13 HG13 ILE ILE 22 143 1.33 10 A A HB3 HA LEU ILE 24 147 1.34 10 A A H HE2 VAL TYR 132 155 1.34 10 A A HG13 H ILE GLU 82 83 1.34 11 A A HB3 HE1 CYS PHE 28 30 1.21 11 A A HD1 HG23 HIS THR 35 76 1.25 11 A A HB2 HG22 ALA THR 49 116 1.33 11 A A HG23 HG22 ILE ILE 26 147 1.34 11 A A H HA ALA GLU 31 127 1.34 12 A A HA2 HB2 GLY ALA 32 123 1.25 12 A A HD1 HG21 HIS THR 35 76 1.31 12 A A HB3 HB LEU ILE 70 91 1.31 12 A A HB3 H ASN SER 94 95 1.32 12 A A HG13 H ILE GLU 82 83 1.33 12 A A O O ALA PRO 31 124 2.15 13 A A HD2 HE22 PRO GLN 61 65 1.20 13 A A HG3 HB2 ARG PHE 29 34 1.24 13 A A HB3 HE1 CYS PHE 28 30 1.34 13 A A O H TYR TYR 42 114 1.48 14 A A HG3 HB2 ARG PHE 29 34 1.22 14 A A HA3 HE1 GLY TYR 80 117 1.26 14 A A H HE2 VAL TYR 132 155 1.30 14 A A HB3 HB LEU ILE 70 91 1.33 14 A A HB3 H LYS ASN 38 39 1.34 15 A A HB2 HB3 ALA LEU 55 135 1.22 15 A A HG H LEU SER 70 71 1.33 15 A A HG13 H ILE GLU 82 83 1.34 15 A A O HA CYS PHE 28 34 1.60 16 A A HG3 HB2 ARG PHE 29 34 1.17 16 A A HB3 HE1 CYS PHE 28 30 1.19 16 A A H HD2 CYS TYR 97 105 1.27 16 A A HD1 HG22 HIS THR 35 76 1.28 16 A A HB HB3 ILE TYR 88 105 1.34 16 A A O H ILE ARG 26 150 1.55 17 A A HD1 HG23 HIS THR 35 76 1.25 17 A A HG3 HB2 ARG PHE 29 34 1.26 18 A A HG22 HB2 VAL LEU 86 107 1.29 18 A A HE2 HB3 HIS ASP 35 115 1.29 18 A A O HA CYS PHE 28 34 1.59 19 A A HB3 HE1 CYS PHE 28 30 1.17 19 A A HG3 HB3 ARG PHE 29 34 1.25 19 A A O HB2 ASN GLU 25 37 1.59 20 A A HA HB2 THR GLN 62 65 1.26 20 A A HB2 HE1 CYS PHE 28 30 1.27 20 A A HG3 HB2 ARG PHE 29 34 1.34 20 A A H HG22 GLN ILE 21 168 1.34 20 A A HD21 HB3 ASN SER 120 122 1.35 1 A ASN 25 -160.07 105.81 1 A CYS 28 154.75 167.85 1 A ALA 31 48.80 28.05 1 A ASN 39 29.01 35.19 1 A ARG 41 28.95 87.39 1 A TYR 42 80.66 -6.41 1 A ALA 49 -48.64 -71.20 1 A PHE 56 -107.18 56.93 1 A ASN 57 34.40 83.15 1 A LEU 60 -36.74 147.48 1 A PRO 61 -59.63 83.58 1 A CYS 77 56.24 15.63 1 A GLU 83 -39.50 -33.74 1 A HIS 85 -174.66 144.02 1 A ARG 90 -171.03 58.87 1 A ILE 96 -163.63 -34.58 1 A CYS 97 -70.52 -75.35 1 A ALA 98 -66.58 -81.11 1 A ALA 99 -158.77 -76.96 1 A ASN 100 -135.05 -61.56 1 A VAL 104 36.28 49.53 1 A THR 108 -159.87 55.14 1 A SER 109 -142.23 -155.74 1 A SER 112 -172.77 -102.00 1 A GLN 113 -164.81 -169.29 1 A TYR 114 -163.38 -161.51 1 A CYS 118 -170.80 121.88 1 A SER 122 -45.76 -76.89 1 A PRO 124 -67.69 -175.30 1 A PRO 125 -58.62 76.76 1 A SER 131 -55.02 89.30 1 A VAL 132 -44.01 -88.28 1 A THR 133 48.01 8.31 1 A ASP 134 -88.09 -79.34 1 A PRO 136 -57.45 2.34 1 A ALA 138 -109.37 -154.46 1 A ARG 150 28.05 -76.39 1 A ASP 151 -156.91 16.53 1 A TYR 161 -173.43 -30.33 1 A ILE 168 -102.54 -74.23 1 A SER 171 -94.83 -77.61 1 A ASP 175 -164.54 98.35 2 A ASN 25 -160.02 102.15 2 A CYS 28 127.49 175.85 2 A ARG 29 -109.05 79.15 2 A ALA 31 71.55 -13.52 2 A ASN 39 -46.86 95.87 2 A ARG 41 -68.38 -154.81 2 A TYR 42 159.85 -5.16 2 A SER 45 -115.00 -165.33 2 A ALA 49 -55.62 -73.16 2 A ASP 51 -62.91 -75.28 2 A PHE 56 -95.52 40.24 2 A CYS 77 -98.85 42.77 2 A ILE 82 -107.18 -158.81 2 A GLU 83 -47.14 -15.24 2 A HIS 85 -172.04 140.04 2 A PRO 89 -65.84 -131.93 2 A ARG 90 68.49 68.83 2 A ILE 91 -37.89 -75.41 2 A PRO 93 -67.69 -87.58 2 A ASN 94 -151.24 20.72 2 A ILE 96 -81.78 -72.18 2 A ALA 99 65.00 -160.66 2 A THR 108 -140.99 59.40 2 A SER 109 -164.66 -20.70 2 A ASN 110 60.20 -89.33 2 A THR 111 60.67 -94.91 2 A SER 112 -92.84 -90.92 2 A GLN 113 -166.60 -114.16 2 A TYR 114 166.73 -171.55 2 A CYS 118 -172.74 121.35 2 A GLU 126 178.88 136.53 2 A GLU 127 -15.30 108.14 2 A THR 130 -48.92 167.91 2 A VAL 132 -52.64 -81.41 2 A THR 133 45.18 15.30 2 A ASP 134 -80.89 -101.19 2 A ALA 138 -61.92 -159.76 2 A PRO 142 -66.81 10.42 2 A THR 144 -66.30 84.32 2 A GLU 160 -178.12 145.82 2 A TYR 161 -178.10 -27.94 2 A SER 171 59.17 95.93 2 A ASP 177 58.46 -166.05 3 A CYS 28 115.70 170.16 3 A ALA 31 58.92 5.01 3 A ASN 39 -50.01 96.60 3 A ARG 41 -67.57 -162.58 3 A TYR 42 169.46 -0.50 3 A SER 45 -108.32 -161.90 3 A ALA 49 -54.31 -75.76 3 A ASP 51 -58.84 -75.24 3 A PHE 56 -87.44 46.71 3 A ASN 57 50.54 72.27 3 A LEU 60 -37.42 102.21 3 A ARG 78 159.43 -105.75 3 A TYR 79 -34.30 129.91 3 A HIS 85 -171.90 144.90 3 A ARG 90 -174.43 47.31 3 A PRO 93 -73.94 31.18 3 A ILE 96 -130.97 -80.70 3 A ALA 98 -65.04 -95.58 3 A ALA 99 176.23 -62.68 3 A ASN 100 -93.07 -116.50 3 A ASN 101 175.32 147.70 3 A THR 102 -170.00 -11.80 3 A THR 111 -145.27 -75.48 3 A SER 112 -137.00 -95.50 3 A GLN 113 -161.17 -117.71 3 A TYR 114 154.07 -143.69 3 A PRO 125 -64.83 66.99 3 A GLU 126 171.38 -137.40 3 A GLU 127 72.87 -143.59 3 A ASP 128 173.05 -90.06 3 A CYS 129 -110.38 -95.42 3 A THR 130 65.90 144.57 3 A SER 131 -58.57 98.63 3 A THR 133 -57.58 9.50 3 A ASP 134 -66.69 -85.29 3 A PRO 136 -64.64 0.48 3 A ALA 138 -67.76 -164.84 3 A PRO 142 -70.06 26.76 3 A THR 144 -67.63 78.79 3 A GLU 160 -164.01 100.17 3 A ARG 162 -80.43 44.99 3 A ASP 175 -108.48 -73.02 4 A CYS 28 143.82 179.96 4 A PHE 30 -79.96 -120.76 4 A ALA 31 -43.07 -8.86 4 A TYR 42 -71.82 37.97 4 A SER 45 -129.06 -141.27 4 A ALA 49 -47.60 -72.27 4 A ALA 50 -37.50 -38.80 4 A PHE 56 -108.34 54.22 4 A ASN 57 39.91 86.50 4 A LEU 60 -46.93 154.49 4 A ILE 82 -109.80 -152.28 4 A ARG 90 -173.44 47.87 4 A ALA 98 58.29 -89.38 4 A ALA 99 -154.97 -79.96 4 A ASN 100 -145.65 -36.01 4 A VAL 104 -69.55 90.71 4 A SER 109 -164.73 -167.27 4 A SER 112 -156.41 -100.96 4 A GLN 113 -122.57 -96.27 4 A TYR 114 108.56 -163.35 4 A GLU 126 -178.50 -84.31 4 A SER 131 -67.39 90.77 4 A VAL 132 -42.71 -90.79 4 A THR 133 44.44 12.81 4 A ASP 134 -87.86 -78.96 4 A PRO 136 -59.95 -2.10 4 A ALA 138 -101.55 -163.31 4 A PRO 142 -68.63 2.64 4 A ARG 150 -59.58 -0.85 4 A GLU 160 -171.19 140.53 4 A TYR 161 -175.77 -33.43 4 A ASN 164 -150.67 84.65 4 A ASP 167 83.21 26.56 4 A ILE 168 53.79 11.34 4 A TYR 169 33.98 79.03 4 A ASP 175 -161.00 -51.97 4 A ASP 176 59.56 15.48 4 A ASP 177 57.29 16.23 5 A CYS 28 137.37 177.85 5 A ARG 29 -109.66 79.14 5 A ALA 31 62.62 -3.98 5 A ASN 39 -56.93 0.00 5 A ARG 41 30.72 83.87 5 A TYR 42 87.48 -6.75 5 A ALA 49 -49.78 -73.17 5 A ASP 51 -51.89 -78.75 5 A PHE 56 -97.64 42.76 5 A PRO 61 -60.22 23.41 5 A THR 62 -46.28 -1.21 5 A CYS 77 56.17 17.74 5 A ILE 82 -105.87 -149.14 5 A GLU 83 -56.28 -6.65 5 A ARG 90 177.39 36.75 5 A ILE 91 29.76 -104.44 5 A HIS 92 -175.52 45.04 5 A PRO 93 -80.11 -73.33 5 A ASN 94 -160.02 15.59 5 A SER 95 59.67 84.06 5 A CYS 97 -98.43 -72.74 5 A ALA 98 -67.51 -96.62 5 A ALA 99 -176.13 -54.26 5 A ASN 100 -60.00 -96.84 5 A ASN 101 -177.35 -167.62 5 A THR 102 54.35 -172.94 5 A THR 111 -155.27 -72.39 5 A SER 112 -165.49 -96.57 5 A GLN 113 -149.56 -153.99 5 A TYR 114 -176.69 -163.16 5 A ASP 115 -85.54 -158.14 5 A GLU 126 177.73 -67.52 5 A GLU 127 179.35 124.79 5 A THR 130 -46.76 161.67 5 A VAL 132 -56.08 -84.81 5 A THR 133 49.50 9.38 5 A ASP 134 -76.55 -101.83 5 A ALA 138 -61.13 -170.15 5 A PRO 142 -68.71 19.51 5 A ASP 151 -79.74 25.91 5 A TYR 161 -143.62 -45.91 5 A THR 163 -81.72 43.61 5 A ILE 168 -105.11 -66.46 5 A ASP 176 -156.08 -54.31 6 A CYS 28 121.75 173.80 6 A ALA 31 62.29 -0.02 6 A SER 43 172.94 -63.44 6 A ALA 49 -51.46 -72.92 6 A ALA 50 -25.73 -48.45 6 A ASP 51 -61.34 -70.70 6 A PHE 56 -104.81 54.40 6 A ASN 57 29.90 78.96 6 A ILE 82 -120.14 -166.31 6 A HIS 85 -164.40 -164.22 6 A PRO 89 -66.24 -172.82 6 A ARG 90 -169.30 -46.11 6 A ILE 91 59.31 -85.54 6 A ILE 96 -150.71 -35.91 6 A CYS 97 -70.73 -80.95 6 A ALA 99 59.65 -164.25 6 A ASN 100 58.14 -91.73 6 A VAL 104 37.17 47.42 6 A THR 111 -168.84 -31.89 6 A SER 112 -76.51 -104.03 6 A TYR 114 174.87 152.67 6 A ASP 115 -79.98 -167.45 6 A GLU 126 -178.15 -60.69 6 A GLU 127 -170.98 127.94 6 A THR 130 -63.06 -147.54 6 A THR 133 -57.26 11.21 6 A LEU 135 -143.48 45.60 6 A PRO 142 -71.30 32.46 6 A ARG 150 -54.68 -3.80 6 A GLU 160 -161.22 116.50 6 A TYR 161 -145.83 33.82 6 A ARG 162 -80.07 38.80 6 A ASP 177 58.57 -166.73 7 A CYS 28 138.33 176.60 7 A ARG 29 -109.83 79.75 7 A ALA 31 64.35 -8.53 7 A ASN 39 -41.72 90.32 7 A SER 43 165.36 -40.96 7 A ILE 44 174.63 172.07 7 A SER 45 -123.31 -168.77 7 A ALA 49 -49.95 -71.57 7 A PHE 56 -112.65 65.92 7 A ASN 57 20.28 70.63 7 A THR 62 -105.76 -165.73 7 A TYR 79 -63.40 76.17 7 A ILE 82 -106.43 -159.50 7 A ARG 90 176.45 49.85 7 A ILE 91 30.39 -104.46 7 A HIS 92 -178.08 52.66 7 A ASN 94 -150.78 -9.78 7 A CYS 97 -94.03 -71.56 7 A ALA 98 -65.94 -83.41 7 A ALA 99 -150.44 -80.19 7 A ASN 100 -141.39 -44.78 7 A THR 108 -80.06 33.19 7 A SER 109 50.75 17.59 7 A ASN 110 -81.29 -80.30 7 A TYR 114 177.17 171.01 7 A GLU 126 -175.94 -75.64 7 A GLU 127 -169.75 113.00 7 A THR 133 -62.53 16.70 7 A ASP 134 -72.09 -106.70 7 A PRO 136 -59.54 0.48 7 A ALA 138 -57.95 -172.40 7 A PHE 139 -107.88 -167.23 7 A PRO 142 -73.37 29.76 7 A ASP 151 -79.15 23.74 7 A TYR 161 -176.92 29.43 7 A ARG 162 -79.88 -72.75 7 A THR 163 66.80 -15.32 7 A PRO 173 -59.66 -71.62 7 A THR 174 -152.53 -17.45 7 A ASP 176 55.62 -163.56 8 A CYS 28 121.48 173.56 8 A ALA 31 57.24 8.36 8 A LYS 38 -102.74 79.40 8 A ASN 39 32.85 27.70 8 A ARG 41 26.62 82.75 8 A TYR 42 85.62 0.70 8 A SER 43 -140.07 41.32 8 A ALA 49 -41.31 -73.64 8 A CYS 53 -38.52 -36.34 8 A PHE 56 -103.43 57.06 8 A ASN 57 34.53 81.29 8 A LEU 60 -38.79 140.75 8 A PRO 61 -62.78 92.33 8 A GLU 75 -171.72 -30.33 8 A THR 76 65.61 -16.28 8 A CYS 77 55.12 10.06 8 A ILE 82 -109.70 -167.34 8 A HIS 85 -166.32 -160.90 8 A ARG 90 177.68 45.74 8 A ILE 91 39.05 -107.82 8 A HIS 92 178.51 51.38 8 A PRO 93 -73.51 -76.03 8 A ASN 94 -160.01 29.93 8 A SER 95 63.06 101.30 8 A ILE 96 -130.86 -72.58 8 A ASN 100 -162.77 -157.74 8 A VAL 104 -118.73 70.48 8 A GLN 113 175.62 54.25 8 A TYR 114 -155.22 -153.97 8 A PRO 125 -65.93 79.43 8 A GLU 126 179.19 164.06 8 A THR 130 -37.06 138.44 8 A SER 131 -58.09 96.42 8 A VAL 132 -79.50 23.41 8 A THR 133 -61.13 7.72 8 A ASP 134 -76.45 -77.91 8 A ALA 138 -62.90 -162.15 8 A PRO 142 -71.28 35.61 8 A THR 144 -66.57 77.93 8 A ARG 150 -56.65 -2.74 8 A GLU 160 -163.56 102.49 8 A ASP 175 -159.31 -70.06 9 A CYS 28 127.50 169.08 9 A ALA 31 49.69 21.95 9 A LYS 38 80.69 -108.36 9 A ASN 39 -59.45 -8.48 9 A TYR 42 63.29 -9.11 9 A SER 43 -161.24 46.61 9 A SER 45 -131.97 -159.86 9 A GLU 48 -54.36 -77.49 9 A CYS 53 -35.35 -36.25 9 A PHE 56 -97.56 54.49 9 A ASN 57 40.01 82.05 9 A LEU 60 -45.11 109.09 9 A THR 62 -109.12 -159.97 9 A TYR 79 -65.27 94.26 9 A HIS 85 -165.97 -161.74 9 A ARG 90 -154.68 61.00 9 A SER 95 -56.61 -72.44 9 A ILE 96 72.46 -24.19 9 A CYS 97 -104.97 -70.39 9 A ALA 98 -58.56 -83.39 9 A ALA 99 -161.30 -74.93 9 A ASN 100 -134.68 -66.46 9 A VAL 104 36.93 47.71 9 A SER 109 -141.10 -82.16 9 A ASN 110 -167.03 -148.99 9 A GLN 113 -177.84 53.43 9 A TYR 114 -147.72 -150.65 9 A CYS 118 -169.92 119.93 9 A SER 122 -47.69 -76.12 9 A PRO 124 -55.10 -178.77 9 A PRO 125 -62.18 81.84 9 A GLU 126 -173.40 148.55 9 A SER 131 -59.30 83.44 9 A VAL 132 -45.34 -88.32 9 A THR 133 47.15 8.07 9 A ASP 134 -81.08 -83.97 9 A PRO 136 -58.33 8.92 9 A ALA 138 -104.19 -164.80 9 A PRO 142 -68.37 14.67 9 A ARG 150 50.88 15.39 9 A ASP 151 83.07 20.23 9 A TYR 161 -177.72 30.15 9 A ARG 162 -80.02 36.40 9 A THR 163 -68.09 1.95 9 A ILE 168 -96.28 -67.86 9 A ASP 176 -134.31 -51.11 10 A ASN 25 -160.05 105.01 10 A CYS 28 114.07 173.95 10 A ASN 39 57.48 13.09 10 A TYR 42 -72.06 28.58 10 A SER 45 -122.28 -151.47 10 A PHE 56 -108.40 43.59 10 A ASN 57 29.66 77.53 10 A CYS 77 -79.96 35.84 10 A PRO 89 -72.67 -118.51 10 A ILE 91 43.67 -98.71 10 A HIS 92 -156.14 -54.09 10 A ILE 96 -169.38 -32.92 10 A ASN 100 -167.88 -80.57 10 A ASN 101 -130.04 -150.58 10 A VAL 104 39.09 42.24 10 A LEU 107 -70.30 -141.97 10 A THR 108 -159.81 17.32 10 A SER 109 -132.92 -64.90 10 A ASN 110 57.41 17.01 10 A SER 112 -93.23 -104.16 10 A GLN 113 -148.98 -90.21 10 A TYR 114 103.57 -159.55 10 A ASP 115 -115.15 -160.73 10 A PRO 124 -52.39 170.34 10 A GLU 126 171.35 -67.65 10 A GLU 127 21.20 -141.85 10 A ASP 128 177.28 -86.37 10 A CYS 129 -143.29 36.82 10 A SER 131 -38.79 97.53 10 A THR 133 -64.48 17.15 10 A ASP 134 -89.01 -76.26 10 A PRO 136 -58.05 -2.09 10 A ALA 138 -87.55 -154.41 10 A ILE 143 -55.54 102.91 10 A THR 144 -65.62 95.15 10 A ARG 150 -58.70 -3.09 10 A GLU 160 -163.87 34.09 10 A ARG 162 -79.93 49.66 10 A ASN 164 -119.38 71.39 10 A ILE 168 -100.65 -63.72 10 A TYR 169 -117.27 74.35 10 A SER 171 56.13 86.72 10 A THR 174 61.00 -88.84 10 A ASP 175 56.84 -160.93 11 A CYS 28 121.44 168.28 11 A ALA 31 54.41 16.55 11 A ASN 39 -49.80 104.73 11 A ARG 41 -73.26 -165.65 11 A TYR 42 160.42 -1.44 11 A SER 45 -109.02 -162.00 11 A THR 47 -32.75 -72.66 11 A ALA 49 -45.15 -74.78 11 A ALA 50 -28.75 -48.37 11 A PHE 56 -100.78 58.08 11 A ASN 57 26.74 75.45 11 A PRO 61 -39.13 -70.61 11 A THR 62 53.74 11.17 11 A CYS 77 56.92 14.38 11 A ILE 82 -106.08 -156.03 11 A GLU 83 -48.10 -14.02 11 A ARG 90 176.01 62.12 11 A ILE 91 -48.84 151.71 11 A HIS 92 66.05 146.92 11 A ILE 96 -125.44 -71.24 11 A CYS 97 -105.01 -83.89 11 A ALA 99 59.39 -163.18 11 A ASN 100 67.06 -92.37 11 A THR 102 -92.17 -144.69 11 A ASN 110 -63.19 -83.51 11 A SER 112 52.89 -100.25 11 A GLN 113 -132.15 -122.88 11 A TYR 114 164.04 -159.66 11 A ASP 115 -79.91 -162.52 11 A GLU 126 -150.65 -77.31 11 A GLU 127 -172.73 133.39 11 A THR 130 -47.82 159.54 11 A SER 131 -57.03 89.44 11 A VAL 132 -63.61 10.98 11 A THR 133 -51.30 5.18 11 A ALA 138 -89.93 -157.71 11 A PRO 142 -71.49 31.59 11 A THR 144 -68.95 80.39 11 A ARG 150 -49.67 -19.94 11 A GLU 160 -162.13 101.92 11 A ARG 162 -79.91 28.62 11 A THR 174 -89.23 -83.42 11 A ASP 175 59.26 15.57 11 A ASP 176 -118.28 -162.66 11 A ASP 177 58.89 18.03 12 A CYS 28 151.79 -173.64 12 A ALA 31 25.42 -95.74 12 A ASN 39 -45.43 99.90 12 A ARG 41 -71.81 -154.20 12 A TYR 42 164.56 -3.36 12 A SER 45 -117.21 -166.36 12 A THR 47 -29.92 -73.36 12 A GLU 48 -58.34 -70.90 12 A ALA 49 -43.31 -70.16 12 A CYS 53 -37.25 -37.86 12 A PHE 56 -96.75 49.24 12 A ASN 57 41.92 83.46 12 A ILE 82 -107.93 -150.19 12 A GLU 83 -58.33 1.03 12 A PRO 89 -65.43 -132.77 12 A ARG 90 74.90 84.40 12 A HIS 92 -170.49 -49.61 12 A PRO 93 -69.62 28.25 12 A ASN 94 -140.32 -108.70 12 A CYS 97 -78.91 -75.43 12 A ALA 98 -62.27 -83.43 12 A VAL 104 -69.26 91.69 12 A SER 112 -63.95 -171.76 12 A GLN 113 -84.43 -111.18 12 A TYR 114 154.78 -160.06 12 A ASP 115 -79.97 -160.31 12 A CYS 118 -171.87 125.37 12 A PRO 124 -70.76 -160.89 12 A PRO 125 -88.65 48.07 12 A GLU 126 -128.61 -95.11 12 A ASP 128 -173.92 95.69 12 A THR 130 -53.72 179.11 12 A SER 131 -59.59 96.54 12 A VAL 132 -83.79 31.34 12 A THR 133 -63.73 18.48 12 A ASP 134 -58.70 -109.90 12 A PRO 136 -64.24 9.62 12 A ALA 138 -60.73 -164.68 12 A PRO 142 -70.68 26.03 12 A THR 144 -65.14 84.56 12 A GLU 160 -176.67 131.87 12 A TYR 161 -174.30 24.46 12 A THR 163 59.85 9.63 13 A CYS 28 149.51 167.46 13 A ALA 31 55.85 3.33 13 A ASN 39 -48.90 99.52 13 A SER 43 -43.66 -5.82 13 A SER 45 -158.92 -134.03 13 A ALA 50 -26.68 -56.93 13 A PHE 56 -106.21 57.39 13 A ASN 57 34.41 82.85 13 A PRO 61 -35.90 -77.48 13 A THR 62 179.24 -161.41 13 A SER 71 -55.31 -7.59 13 A ARG 78 -148.93 -107.27 13 A TYR 79 -154.29 74.12 13 A ILE 82 -100.46 -158.16 13 A GLU 83 -49.67 -13.77 13 A PRO 89 -64.14 -176.09 13 A ARG 90 -167.24 3.74 13 A ILE 91 61.27 -88.94 13 A PRO 93 -73.23 24.36 13 A SER 95 55.38 73.92 13 A CYS 97 -85.70 -93.87 13 A ALA 99 58.01 -175.75 13 A THR 102 -78.45 -143.36 13 A VAL 104 -143.79 48.43 13 A SER 109 -172.30 114.79 13 A THR 111 -175.31 -27.63 13 A SER 112 -89.79 -121.71 13 A TYR 114 174.56 -168.81 13 A PRO 125 -66.72 71.42 13 A SER 131 -31.05 92.14 13 A THR 133 -63.03 14.97 13 A ASP 134 -75.34 -87.99 13 A PRO 136 -58.88 -3.46 13 A PRO 142 -69.86 8.93 13 A GLU 160 -170.00 136.25 13 A TYR 161 -177.47 26.64 13 A THR 163 58.47 11.59 13 A PRO 165 -57.36 -9.00 13 A THR 174 -69.24 -158.07 13 A ASP 175 61.03 -159.55 14 A CYS 28 131.88 175.37 14 A ARG 29 -110.13 77.93 14 A ALA 31 65.35 -11.26 14 A LYS 38 75.26 -114.30 14 A ASN 39 -57.63 -5.77 14 A TYR 42 67.29 -13.81 14 A SER 43 -141.72 23.59 14 A SER 45 -132.43 -153.69 14 A GLU 48 -53.21 -76.24 14 A ASN 57 39.20 88.91 14 A THR 59 -83.19 -147.04 14 A LEU 60 -155.04 66.63 14 A THR 62 58.23 -108.04 14 A MET 63 -31.19 -38.90 14 A TYR 79 -55.05 86.00 14 A PHE 81 -45.97 152.20 14 A ILE 82 -160.03 -164.52 14 A HIS 85 92.97 -160.17 14 A ARG 90 175.04 63.64 14 A ILE 91 -59.21 -74.13 14 A HIS 92 -155.06 54.04 14 A PRO 93 -71.25 -91.74 14 A ASN 94 -160.01 22.89 14 A ALA 98 75.53 -46.58 14 A ALA 99 60.90 -171.51 14 A ASN 101 -179.11 147.35 14 A VAL 104 -61.66 92.34 14 A SER 112 -138.21 -90.28 14 A GLN 113 -171.80 110.07 14 A TYR 114 -147.43 -150.32 14 A GLU 126 -176.24 -65.59 14 A GLU 127 -179.91 120.83 14 A THR 130 -46.43 155.58 14 A THR 133 -60.54 12.49 14 A ASP 134 -60.97 -108.90 14 A PRO 136 -67.99 10.65 14 A ALA 138 -62.32 -167.83 14 A PHE 139 -113.05 -167.69 14 A PRO 142 -74.33 32.69 14 A TYR 161 -176.13 25.16 14 A THR 163 57.15 11.97 14 A ILE 168 -107.96 -67.61 14 A TYR 169 -116.87 76.88 14 A THR 174 -148.43 -29.98 14 A ASP 177 53.69 -160.54 15 A CYS 28 143.75 179.78 15 A PHE 30 -79.96 -117.20 15 A ALA 31 -49.24 2.16 15 A ASN 39 24.22 41.08 15 A ARG 41 29.02 86.65 15 A TYR 42 79.90 -8.64 15 A CYS 53 -39.60 -34.97 15 A PHE 56 -116.32 64.15 15 A ASN 57 16.48 69.93 15 A THR 59 -108.30 -141.16 15 A LEU 60 -163.65 65.73 15 A THR 62 76.65 -124.23 15 A SER 71 -58.15 1.85 15 A CYS 77 55.79 14.46 15 A ILE 82 -110.15 -150.94 15 A PRO 89 -60.51 -174.07 15 A ARG 90 -166.61 -51.47 15 A ILE 91 56.26 -89.23 15 A HIS 92 -169.69 -52.74 15 A ALA 98 -62.01 -80.25 15 A ALA 99 -148.87 -86.59 15 A ASN 100 -140.60 -42.05 15 A THR 111 -104.09 -67.63 15 A SER 112 -161.09 -83.45 15 A GLN 113 -152.06 -150.08 15 A TYR 114 -167.76 -168.62 15 A ASP 115 -97.42 -150.87 15 A GLU 126 -159.04 -84.95 15 A GLU 127 -163.46 119.67 15 A THR 133 -57.47 4.98 15 A ASP 134 -79.98 -81.28 15 A PRO 136 -54.62 -2.61 15 A PRO 142 -73.35 24.16 15 A GLU 160 -170.49 132.63 15 A TYR 161 -176.02 26.53 15 A THR 163 57.53 15.90 15 A ILE 168 -104.00 -65.61 15 A PRO 170 -50.56 105.37 15 A THR 174 -150.82 -26.43 16 A CYS 28 126.63 168.80 16 A ARG 29 -104.40 79.78 16 A LYS 38 77.03 -122.15 16 A ASN 39 -56.02 -9.70 16 A TYR 42 63.13 -9.82 16 A SER 43 -152.99 37.39 16 A SER 45 -122.39 -165.23 16 A GLU 48 -54.35 -74.80 16 A CYS 53 -36.42 -35.47 16 A ALA 55 -35.64 -35.87 16 A PHE 56 -107.92 55.59 16 A ASN 57 39.18 85.70 16 A TYR 79 64.33 67.07 16 A ILE 82 -111.31 -162.49 16 A HIS 85 -174.66 141.74 16 A PRO 89 -27.08 136.61 16 A ILE 91 -62.36 -71.99 16 A HIS 92 -171.75 42.21 16 A PRO 93 -87.31 -100.35 16 A ASN 94 -160.03 27.12 16 A SER 95 69.56 155.17 16 A ILE 96 72.25 104.45 16 A ALA 99 -129.30 -66.45 16 A ASN 101 72.18 121.31 16 A THR 102 64.61 139.21 16 A VAL 104 -51.67 100.39 16 A SER 109 -153.29 44.92 16 A ASN 110 59.46 17.88 16 A THR 111 54.21 91.44 16 A SER 112 -91.94 -88.51 16 A TYR 114 -140.62 -143.90 16 A GLU 126 -175.22 -56.93 16 A GLU 127 -175.90 136.78 16 A SER 131 -52.43 97.74 16 A PRO 136 -52.56 10.15 16 A PRO 142 -69.85 11.57 16 A ILE 143 -54.09 101.65 16 A THR 144 -65.36 77.11 16 A ARG 150 52.84 12.97 16 A ASP 151 85.84 5.37 16 A GLU 160 -170.61 122.76 16 A TYR 161 -176.70 25.57 16 A ARG 162 -86.28 -71.02 16 A ILE 168 -103.62 -66.52 16 A TYR 169 -112.90 74.42 16 A SER 171 60.32 102.60 16 A ASP 176 -134.46 -30.93 17 A CYS 28 128.97 176.07 17 A ARG 29 -110.38 79.19 17 A ALA 31 69.20 -13.39 17 A ASN 39 -56.35 84.87 17 A TYR 42 157.76 4.87 17 A SER 43 -156.48 41.30 17 A ALA 49 -50.83 -70.12 17 A ASP 51 -60.22 -73.66 17 A PHE 56 -92.65 43.90 17 A CYS 77 -78.73 40.79 17 A ILE 82 -111.84 -151.50 17 A GLU 83 -55.88 -2.26 17 A PRO 89 -62.76 -157.81 17 A ARG 90 69.86 113.13 17 A ILE 91 -58.13 -72.68 17 A HIS 92 -166.19 54.16 17 A PRO 93 -68.84 -79.88 17 A ASN 94 -153.11 -15.20 17 A SER 95 60.88 99.79 17 A ALA 98 -65.14 -85.88 17 A ALA 99 -158.95 -99.78 17 A VAL 104 37.62 48.16 17 A THR 108 -80.01 -98.77 17 A THR 111 -153.30 -78.24 17 A GLN 113 -75.29 -140.06 17 A TYR 114 173.95 -159.31 17 A ASP 115 -82.45 -159.48 17 A GLU 126 -179.14 -67.16 17 A GLU 127 172.52 121.06 17 A THR 130 -43.36 154.21 17 A SER 131 -49.02 94.12 17 A THR 133 -63.95 19.67 17 A ASP 134 -66.60 -110.40 17 A PRO 136 -62.21 17.87 17 A ALA 138 -60.79 -166.95 17 A PRO 142 -70.40 25.97 17 A ARG 150 -54.89 -8.14 17 A GLU 160 -144.94 -65.67 17 A TYR 161 48.24 23.32 17 A ILE 168 -105.07 -63.88 17 A TYR 169 -117.28 77.36 17 A PRO 170 -50.49 -80.23 18 A CYS 28 148.13 -169.25 18 A ALA 31 53.85 8.34 18 A ASN 39 29.07 35.21 18 A ARG 41 31.82 84.87 18 A TYR 42 79.95 -2.91 18 A SER 45 -119.46 -166.33 18 A ALA 49 -50.30 -77.81 18 A PHE 56 -103.96 53.38 18 A ASN 57 27.45 78.36 18 A THR 59 -104.68 -153.56 18 A LEU 60 -146.85 55.64 18 A THR 62 79.12 -94.43 18 A SER 71 -55.13 -4.52 18 A CYS 77 47.05 22.98 18 A HIS 85 88.96 -161.38 18 A PRO 89 -66.78 -161.11 18 A ARG 90 -173.23 -50.80 18 A ILE 91 55.27 -88.76 18 A HIS 92 -170.47 -53.67 18 A ASN 94 -84.13 49.84 18 A ALA 98 -128.86 -79.31 18 A ALA 99 -153.27 -158.61 18 A THR 108 -160.01 96.05 18 A SER 109 -155.86 -89.50 18 A THR 111 66.77 127.16 18 A SER 112 -166.92 -87.44 18 A TYR 114 -157.39 -156.76 18 A GLU 126 -163.39 -59.72 18 A GLU 127 -171.44 140.32 18 A ASP 128 -162.98 115.71 18 A THR 130 -54.79 -177.51 18 A SER 131 -54.25 87.92 18 A THR 133 -57.87 11.34 18 A ASP 134 -54.01 -100.98 18 A PRO 136 -62.83 8.59 18 A ALA 138 -70.17 -159.95 18 A PRO 142 -72.16 25.50 18 A THR 144 -66.30 91.90 18 A ARG 150 49.11 8.97 18 A ASP 151 80.68 0.51 18 A TYR 161 179.77 29.65 18 A ARG 162 -85.05 39.40 19 A CYS 28 131.99 170.70 19 A ALA 31 56.22 11.99 19 A ASN 39 -30.37 89.16 19 A SER 43 169.05 -21.87 19 A ILE 44 158.29 166.30 19 A ARG 46 -73.04 -70.18 19 A PHE 56 -107.77 65.38 19 A ASN 57 19.92 69.09 19 A CYS 77 -78.62 35.58 19 A ILE 82 -106.57 -157.87 19 A GLU 83 -52.18 -5.80 19 A PRO 89 -58.52 -177.05 19 A ARG 90 -161.82 -21.91 19 A ASN 94 -155.91 59.07 19 A ILE 96 57.49 15.68 19 A CYS 97 -70.13 -78.52 19 A ALA 99 64.68 155.81 19 A ASN 100 58.65 19.89 19 A THR 102 -158.18 6.29 19 A VAL 104 -141.98 32.18 19 A THR 108 -150.40 61.79 19 A SER 109 -151.85 -145.48 19 A CYS 118 -162.14 106.61 19 A GLU 126 -171.64 -55.00 19 A GLU 127 -171.04 133.39 19 A SER 131 -30.19 104.21 19 A VAL 132 -49.47 -95.39 19 A THR 133 53.58 0.97 19 A ASP 134 -75.49 -85.81 19 A PRO 136 -61.78 10.72 19 A PRO 142 -73.39 20.06 19 A THR 144 -63.34 86.21 19 A GLU 160 -173.07 131.65 19 A TYR 161 -175.63 28.55 19 A ARG 162 -80.89 37.89 19 A THR 163 -64.79 4.34 19 A ILE 168 -103.36 -70.26 20 A CYS 28 125.48 178.76 20 A ASN 39 19.45 44.49 20 A ARG 41 27.22 88.30 20 A TYR 42 80.15 -6.77 20 A ALA 49 -47.66 -73.41 20 A ASN 57 37.84 85.28 20 A PRO 61 -53.69 10.92 20 A THR 62 -42.28 -5.85 20 A CYS 77 57.66 12.88 20 A ILE 82 -82.13 -151.85 20 A GLU 83 -48.97 -18.02 20 A VAL 86 -52.72 100.31 20 A ARG 90 -179.24 53.63 20 A ILE 96 55.73 19.70 20 A CYS 97 -95.94 -74.95 20 A ALA 99 56.51 77.59 20 A ASN 100 -138.43 -99.97 20 A ASN 101 -174.31 -47.43 20 A SER 109 -83.51 -152.33 20 A THR 111 -63.61 -83.89 20 A SER 112 53.42 -102.20 20 A GLN 113 -172.81 -163.00 20 A ASP 115 -98.21 -156.07 20 A CYS 118 -169.65 118.49 20 A GLU 126 166.79 -64.28 20 A GLU 127 28.70 -146.42 20 A ASP 128 -176.62 -149.37 20 A VAL 132 -50.01 -88.73 20 A THR 133 70.33 -22.72 20 A PRO 136 -59.28 -1.90 20 A ALA 138 -99.45 -149.81 20 A PHE 139 -148.55 -115.63 20 A THR 144 -59.76 90.36 20 A GLU 160 178.19 152.10 20 A TYR 161 -160.67 -31.44 20 A PRO 165 -56.46 -9.41 20 A SER 171 63.44 171.15 SOLUTION STRUCTURE OF THE HYALURONAN BINDING DOMAIN OF HUMAN CD44 1 N N A SER 45 A SER 26 HELX_P A PHE 56 A PHE 37 1 1 12 A THR 62 A THR 43 HELX_P A ILE 72 A ILE 53 1 2 11 A ASN 164 A ASN 145 HELX_P A ILE 168 A ILE 149 5 3 5 disulf 2.031 A CYS 28 A SG CYS 9 1_555 A CYS 129 A SG CYS 110 1_555 disulf 2.029 A CYS 53 A SG CYS 34 1_555 A CYS 118 A SG CYS 99 1_555 disulf 2.030 A CYS 77 A SG CYS 58 1_555 A CYS 97 A SG CYS 78 1_555 CELL ADHESION HYALURONAN-BINDING DOMAIN, CARBOHYDRATE-BINDING DOMAIN, LINK MODULE, CELL ADHESION, GLYCOPROTEIN CD44_HUMAN UNP 1 20 Q16208 AQIDLNITCRFAGVFHVEKNGRYSISRTEAADLCKAFNSTLPTMAQMEKALSIGFETCRYGFIEGHVVIPRIHPNSICAA NNTGVYILTSNTSQYDTYCFNASAPPEEDCTSVTDLPNAFDGPITITIVNRDGTRYVQKGEYRTNPEDIYPSNPTDDDV 20 178 1POZ 20 178 Q16208 A 1 1 159 3 3 2 2 3 parallel anti-parallel parallel anti-parallel anti-parallel anti-parallel anti-parallel parallel A GLN 21 A GLN 2 A ASP 23 A ASP 4 A PHE 139 A PHE 120 A ASN 149 A ASN 130 A THR 153 A THR 134 A TYR 155 A TYR 136 A GLN 21 A GLN 2 A ASP 23 A ASP 4 A PHE 139 A PHE 120 A ASN 149 A ASN 130 A LYS 158 A LYS 139 A GLU 160 A GLU 141 A ARG 29 A ARG 10 A PHE 30 A PHE 11 A VAL 33 A VAL 14 A PHE 34 A PHE 15 A SER 58 A SER 39 A THR 59 A THR 40 A PHE 119 A PHE 100 A ASN 120 A ASN 101 A VAL 86 A VAL 67 A VAL 87 A VAL 68 A GLY 80 A GLY 61 A PHE 81 A PHE 62 A ASP 115 A ASP 96 A THR 116 A THR 97